Chicago, IL, United States of America

Ryan Nicholas Gilbreth


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):

Title: Ryan Nicholas Gilbreth: Innovator in Fibronectin Cradle Molecules

Introduction

Ryan Nicholas Gilbreth is an accomplished inventor based in Chicago, IL. He holds a patent that showcases his innovative contributions to the field of molecular biology. His work focuses on the development of fibronectin cradle molecules, which have significant implications for various applications in biochemistry and medicine.

Latest Patents

Gilbreth's notable patent is titled "Fibronectin cradle molecules and libraries thereof." This invention discloses a combination of a top and bottom loop binder library utilizing the CD and FG loops of several FnIII domains. The invention also includes a method for forming a library of FnIII domain polypeptides, which can be used to screen for polypeptides with specific binding or enzymatic activities. This patent highlights his expertise in molecular design and protein engineering.

Career Highlights

Throughout his career, Ryan Nicholas Gilbreth has worked with prominent organizations, including Novartis AG and the University of Chicago. His experience in these institutions has allowed him to refine his skills and contribute to significant advancements in his field. His work has been instrumental in bridging the gap between academic research and practical applications in the pharmaceutical industry.

Collaborations

Gilbreth has collaborated with notable colleagues, including Andreas Loew and Brian Edward Vash. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Ryan Nicholas Gilbreth is a distinguished inventor whose work on fibronectin cradle molecules has made a meaningful impact in the field of molecular biology. His contributions continue to inspire advancements in research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…